MedPath

Isolation of Volatile Organic Compounds (VOCs) Related to the Olfactory Signature of Breast Cancer

Not Applicable
Completed
Conditions
Surgery
Breast Cancer
Interventions
Diagnostic Test: Sorbstar®
Diagnostic Test: Odour sampling
Registration Number
NCT03703557
Lead Sponsor
Institut Curie
Brief Summary

To ascertain the possibilities to isolate the breast cancer olfactive signature.

Detailed Description

Patient recruitment during the first surgery consultation in Curie Institute. Odor sampling (non-invasive) with an odor-sensing polymer (Sorbstar® polymer developed especially for the trace level analysis), on:

* The hands, before and after surgical excision of the tumor (friction of the hands)

* The diseased breast, before and after surgical excision of the tumor (via a compress positioned on the breast for 1 night)

* The tumor, during the surgical procedure (odor collection over a tumor sample).

Each patient will be her own witness, before and after surgical excision, in an attempt to isolate the chemical signature tracks of breast cancer. The samples after surgery will be made after healing and before implementation of a treatment (chemotherapy and / or radiotherapy).

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
15
Inclusion Criteria
  1. Patient received in surgery consultation for an invasive non metastatic breast cancer treated by breast-conserving surgery with axillary or sentinel node dissection
  2. Of-Age female patient (over 18 years old)
  3. Life expectancy > to 1 year at the inclusion
  4. Performance status: 0 or 1 or 2
  5. Patient benefiting from the social security
  6. Signature informed consent of the study
Read More
Exclusion Criteria
  1. Neoplasia in progress or neoplasia history of cancer other than breast to be treated.
  2. Wound presence on breasts
  3. Male subjects
  4. Specified metastatic breast cancer
  5. Concomitant medication taken one month before the surgical act (antibiotics, corticoids, anti-diabetics)
  6. Persons under guardianship or deprived of liberty
  7. Impossibility to submit to the medical monitoring expected by the study for geographical, social or psychological reasons.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SEQUENTIAL
Arm && Interventions
GroupInterventionDescription
Sorbstar®Sorbstar®Odour sampling: Rub hands with Sorbstar® before and post-surgery
Dog detectionOdour samplingOdour sampling: Sleep over a night with a compress on the affected breast before and after surgery
Primary Outcome Measures
NameTimeMethod
Ascertain breast cancer olfactive signature (Isolation of volatile Organic Compounds to breast cancer by a sensitive technique with an odor-sensing polymer (Sorbstar®)12 months

Isolation of volatile Organic Compounds to breast cancer by a sensitive technique with an odor-sensing polymer (Sorbstar®) on hands. Friction of the hands according to the protocol before and after surgical excision of the tumor. Sorbstar® analyses will be performed with a thermodesorption method coupled with full two-dimensional gas chromatography and mass spectrometry.

Secondary Outcome Measures
NameTimeMethod
Ascertain breast cancer detection by the dogs of Curie Institut13 months

Patients sleep over a night with a compress positioned on the affected breast before and after surgery. The compress will be analyzed by the dogs of Curie Institut (results cancer/not cancer).

Ascertain breast cancer olfactive signature from the tumor (Isolation of volatile Organic Compounds to tumor breast samples by a sensitive technique with an odor-sensing polymer (Sorbstar®).13 months

During the surgical procedure an odor-sensing polymer (Sorbstar®) over the tumor is placed. Sorbstar® analyzes will be performed with a thermodesorption method coupled with full two-dimensional gas chromatography and mass spectrometry.

Trial Locations

Locations (1)

INSTITUT CURIE - Site de Saint Cloud

🇫🇷

Saint-Cloud, France

© Copyright 2025. All Rights Reserved by MedPath